ADMA announced the FDA's approval of its yield enhancement process. The company's yield enhancement process has demonstrated the ability to increase production yields by approximately 20%.

ADMA reaffirmed its previously provided financial guidance for both 2025 and 2026. For 2025, management expects total revenue of $500 million or more, adjusted EBITDA of at least $235 million, and ...

This press release contains “forward-looking statements” pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, about ADMA Biologics, Inc. (“we,” “our” or the ...

(RTTNews) - ADMA Biologics, Inc. (ADMA) Monday said that the United States Food and Drug Administration (FDA) has approved the company's innovative production yield enhancement process. The company ...

Everybody seems to be loving yield, and the Wall Street financial engineering machine is happy to produce yield in seemingly magical ways. Products abound promising 10%, 20% and even over 50% ...

The Processors and Growers Research Organisation (PGRO) will take ownership of the pea and bean Yield Enhancement Networks (YEN) this autumn with the aim of modernising them for today's pulse grower.

--ADMA Biologics, Inc., a U.S. based, end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty biologics, today announced U.S. FDA approval of its ...